- Home
- DYN vs GRDN Comparison
DYN vs GRDN Comparison
Compare DYN & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | GRDN |
|---|---|---|
| Founded | 1984 | 2004 |
| Country | United States | United States |
| Employees | N/A | 3600 |
| Industry | Medicinal Chemicals and Botanical Products | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | DYN | GRDN |
|---|---|---|
| Price | $20.13 | $37.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $37.00 | ★ $40.25 |
| AVG Volume (30 Days) | ★ 1.8M | 445.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.63 |
| P/E Ratio | ★ N/A | $117.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.25 | $19.17 |
| 52 Week High | $25.00 | $41.36 |
Technical Indicators
Market Signals| Indicator | DYN | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 52.41 |
| Support Level | $18.32 | $31.48 |
| Resistance Level | $21.00 | $37.78 |
| Average True Range (ATR) | 1.08 | 1.38 |
| MACD | 0.15 | -0.32 |
| Stochastic Oscillator | 66.31 | 17.28 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About GRDN Guardian Pharmacy Services Inc.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.